Announcement / Upcoming Event


You're welcome to get in touch with us should you wish to make an enquiry, arrange an appointment or give us feedback about our website and/or products and services. We'd love to hear from you.
Introducing the Next Generation of Targeted Phototherapy

The DualLightTM is cleared by the FDA for the treatment of psoriasis, vitiligo, atopic dermatitis and seborrheic dermatitis. It is the first targeted phototherapy system to emit either UVA or UVB via a flexible light guide and handpiece.

The patented design of the square handpiece aperture allows for the treatment of contiguous skin segments, without exposing neighboring, healthy skin. This design also allows healthy skin. This design also allows for the delivery of high dose UV light (e.g. 6-8 MEDs/MPD/s) which has been shown to reduce the total number of treatment sessions required.

The system is ideal for the treatment of localized disease, including knees, elbows, hands, feet, nails and scalp.

Patient Benefits
• High dose therapy yields rapid result
• Fewer treatments required
• No need to fully disrobe
• Healthy skin not exposed to UV light
• Minimal side effects
• Greater convenience
Physician Benefits
• Easy to operate
• Allows for targeted PUVA
• Fast treatment times
• No special electrical requirements
• Countertop design
• Easy MED/MPD determination
• Stand alone use or as adjunct to booth
• Low maintenance
• Affordable technology

The system is small and light weight. It may be placed on a counter top, or a mobile cart.

Treatments are fast and easy to perform. A 100 mj/cm² UVB dose is delivered in about 0.7 seconds, while a 1.0J/cm ² does takes about 4 seconds. A typical treatment session may e completed in minutes.

The patient pictured below underwent 4 treatments, twice @ 8 MEDs and twice @ 2 MEDs.

Aesthetic Medicine